EMERYVILLE,
Calif., Feb. 28,
2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a
leading synthetic biotechnology company accelerating the world's
transition to sustainable consumption through its Lab-to-Market™
technology platform today announced that management will
participate in a fireside chat at the 42nd Annual Cowen
Health Care Conference on Monday, March 7,
2022, at 1:30 pm ET.
A live webcast of the presentation and a replay will be
available on the Investor Relations section of the company's
website at
https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ technology platform. This Amyris technology platform
leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products. For more information, please visit
http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original
content:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-42nd-annual-cowen-health-care-conference-301491274.html
SOURCE Amyris, Inc.